Connacht Asset Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-59,043
Closed -$825K 155
2022
Q1
$1.35M Sell
59,043
-2,382
-4% -$58.2K 0.69% 38
2021
Q4
$1.7M Buy
61,425
+12,491
+26% +$334K 1.65% 19
2021
Q3
$1.36M Sell
48,934
-34,775
-42% -$986K 0.88% 38
2021
Q2
$2.45M Buy
83,709
+376
+0.5% +$11.4K 1.06% 23
2021
Q1
$2.65M Sell
83,333
-10,117
-11% -$297K 0.59% 49
2020
Q4
$1.94M Buy
+93,450
New +$1.74M 0.92% 36

Other funds holding BHC

Connacht Asset Management's BHC Position: Q2 2022 in Review

Connacht Asset Management sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 59,043 shares — an estimated $825K sold.

Connacht Asset Management first reported a position in BHC in Q4 2020 and held it in 6 quarters. The position peaked at $2.65M in Q1 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Connacht Asset Management reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Connacht Asset Management sold 59,043 Bausch Health shares in Q2 2022, an estimated $825K.
  • Connacht Asset Management first reported a position in Bausch Health in Q4 2020 and held it in 6 quarters.
  • Connacht Asset Management's Bausch Health position peaked at $2.65M in Q1 2021.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Connacht Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.